FDA faults Biocon small molecule API facility during preapproval review

29th January 2020 Uncategorised 0

The FDA has found a handful of issues with Biocon’s small molecule API facility in Bengaluru, India.

More: FDA faults Biocon small molecule API facility during preapproval review
Source: fierce